English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 欧州における心血管治療薬市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州における心血管治療薬市場

European Cardiovascular Drugs Markets

発行 Frost & Sullivan
出版日 2006年09月 商品コード 45500
ページ情報 英文 149 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research examines the European Cardiovascular Market in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts and growth rates and strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • 1. Overview of the European Cardiovascular Drugs Market

2. GLOSSARY OF TERMS

List of Terms

  • 1. Abbreviations

3. INTRODUCTION

Disease State Overview

  • 1. Disease Description and Risk Factors
  • 2. Types of Heart Disease
  • 3. Disease Management and Current Treatments

Research Methodology

  • 1. Research Methodology for the European Cardiovascular Drugs Market
  • 2. Assumptions and Limitations

4. INDUSTRY CHALLENGES

Challenges and Issues

  • 1. Challenges Facing the European Cardiovascular Drugs Market

5. MARKET ENGINEERING RESEARCH FOR WORLD CARDIOVASCULAR DRUGS MARKET

World Cardiovascular Drugs Market

  • 1. Introduction
  • 2. Measurement Analysis
  • 3. Revenue Forecasts
  • 4. Trends by Geographic Regions
  • 5. Segment Analysis

6. MARKET ENGINEERING RESEARCH FOR EUROPEAN CARDIOVASCULAR DRUGS MARKET

European Cardiovascular Drugs Market

  • 1. Introduction and Market Segmentation
  • 2. Measurements Analysis
  • 3. Key Market Drivers
  • 4. Key Market Restraints
  • 5. Revenue Forecasts
  • 6. Segment-wise Analysis

7. CARDIOVASCULAR DRUGS MARKET IN THE UNITED KINGDOM

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

8. CARDIOVASCULAR DRUGS MARKET IN GERMANY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

9. CARDIOVASCULAR DRUGS MARKET IN FRANCE

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

10. CARDIOVASCULAR DRUGS MARKET IN ITALY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

11. CARDIOVASCULAR DRUGS MARKET IN SPAIN

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

12. PORTFOLIO ANALYSIS

Company Profiles and Product Pipeline

  • 1. AstraZeneca
  • 2. Bristol-Myers Squibb
  • 3. Merck & Co. Inc
  • 4. Novartis
  • 5. Pfizer
  • 6. Sanofi-Aventis

13. STRATEGIC RECOMMENDATIONS

Recommendations

  • 1. Strategic Recommendations for the European Cardiovascular Drugs Market

14. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • 1. Major Participants

15. DECISION SUPPORT DATABASES

Cardiovascular Diseases

  • 1. Cardiovascular Prevalence
  • 2. Percent of Cardiovascular Disease Prevalence
  • 3. Prevalence of Hypertension
  • 4. Prevalence of Hypertension as Percentage of Population
  • 5. Incidence of Myocardial Infarction
  • 6. Incidence of Stroke
  • 7. Mortality due to Coronary Heart Disease
  • 8. Mortality due to Circulatory Disease
  • 9. Mortality due to Chronic Rheumatic Heart Disease
  • 10. Heart Attack Mortality
  • 11. Mortality due to Hypertensive Diseases
Back to Top